Literature DB >> 30771197

Cyclohexane Inhalation Produces Long-Lasting Alterations in the Hippocampal Integrity and Reward-Seeking Behavior in the Adult Mouse.

Tania Campos-Ordonez1,2, David Zarate-Lopez1,2, Nereida Ibarra-Castaneda1, Jonathan Buritica3, Oscar Gonzalez-Perez4.   

Abstract

Cyclohexane (CHX) is an organic solvent commonly used as a drug-of-abuse. This drug increases the oxidative stress and glial reactivity in the hippocampus, which suggests that this brain region is vulnerable to CHX effects. This study aimed to establish the behavioral changes and the pathological alterations that occur in the Cornu Ammonis 3 (CA3) and Dentate Gyrus (DG) after a long-lasting exposure to CHX. We exposed CD1 mice to a recreational-like dose of CHX (~ 30,000 ppm) for 30 days and explored its consequences in motor skills, reward-seeking behavior, and the CA3 and DG hippocampal subfields. Twenty-four hours after the last administration of CHX, we found a significant decrease in the number of c-Fos+ cells in the hippocampal CA3 and DG regions. This event coincided with an increased in NMDAR1 expression and apoptotic cells in the CA3 region. At day 13th without CHX, we found a persistent reduction in the number of c-Fos+ and TUNEL+ cells in DG. At both time points, the CHX-exposed mice showed a strong overexpression of neuropeptide Y (NPY) in the CA3 stratum lucidum and the hippocampal hilus. In parallel, we used an operant-based task to assess motor performance and operant conditioning learning. The behavioral analysis indicated that CHX did not modify the acquisition of operant conditioning tasks, but affected some motor skills and increased the reward-seeking behavior. Altogether, this evidence reveals that CHX exposure provokes long-lasting changes in the hippocampal subfields, induces motor impairments and increases the motivation-guided behavior. These findings can help understand the deleterious effect of CHX into the adult hippocampus and unveil its potential to trigger addiction-like behaviors.

Entities:  

Keywords:  Apoptosis; Excitotoxicity; Hippocampus; Inhalant abuse; Motor skills; NMDAR1; Neuropeptide Y; Reward motivation; Solvent

Mesh:

Substances:

Year:  2019        PMID: 30771197     DOI: 10.1007/s10571-019-00660-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  62 in total

Review 1.  The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies.

Authors:  Scott E Bowen; Jeffery C Batis; Nayeli Paez-Martinez; Silvia L Cruz
Journal:  Neurotoxicol Teratol       Date:  2006-09-20       Impact factor: 3.763

2.  Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.

Authors:  Claudio Acuna-Goycolea; Nobuaki Tamamaki; Yuchio Yanagawa; Kunihiko Obata; Anthony N van den Pol
Journal:  J Neurosci       Date:  2005-08-10       Impact factor: 6.167

3.  c-fos regulates neuronal excitability and survival.

Authors:  Jianhua Zhang; Dongsheng Zhang; Jill Slane McQuade; Michael Behbehani; Joe Z Tsien; Ming Xu
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

4.  Aberrant expression of neuropeptide Y in hippocampal mossy fibers in the absence of local cell injury following the onset of spike-wave synchronization.

Authors:  R S Chafetz; W K Nahm; J L Noebels
Journal:  Brain Res Mol Brain Res       Date:  1995-07

5.  The combined therapy of intrahippocampal transplantation of adult neural stem cells and intraventricular erythropoietin-infusion ameliorates spontaneous recurrent seizures by suppression of abnormal mossy fiber sprouting.

Authors:  Meng Jing; Tetsuro Shingo; Takao Yasuhara; Akihiko Kondo; Takamasa Morimoto; Feifei Wang; Tanefumi Baba; Wen Ji Yuan; Naoki Tajiri; Takashi Uozumi; Mayu Murakami; Mariko Tanabe; Yasuyuki Miyoshi; Shiguang Zhao; Isao Date
Journal:  Brain Res       Date:  2009-07-30       Impact factor: 3.252

Review 6.  The effects of toluene on the central nervous system.

Authors:  Christopher M Filley; William Halliday; B K Kleinschmidt-DeMasters
Journal:  J Neuropathol Exp Neurol       Date:  2004-01       Impact factor: 3.685

Review 7.  Neuropeptide Y: emerging evidence for a functional role in seizure modulation.

Authors:  A Vezzani; G Sperk; W F Colmers
Journal:  Trends Neurosci       Date:  1999-01       Impact factor: 13.837

Review 8.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.

Authors:  Barry J Everitt; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

9.  Neuropeptide Y and Epilepsy.

Authors:  William F. Colmers; Bouchaïb El Bahh
Journal:  Epilepsy Curr       Date:  2003-03       Impact factor: 7.872

10.  Cyclohexane, a Potential Drug of Abuse with Pernicious Effects on the Brain.

Authors:  Tania Campos-Ordonez; Oscar Gonzalez-Perez
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.